Advisory Board February 2, 2024
The Biden administration on Thursday sent pharmaceutical companies initial offers for 10 drugs that will be part of Medicare’s new drug price negotiation program under the Inflation Reduction Act (IRA). However, the program is the subject of several ongoing lawsuits filed by drug manufacturers that have argued the law is unconstitutional.
Background
The IRA, which was signed into law in August 2022, includes several drug pricing provisions. Under the law, Medicare will be able to negotiate certain prescription drug prices with pharmaceutical companies. This provision will initially apply...